Cargando…
Serum Autoantibodies against LRDD, STC1, and FOXA1 as Biomarkers in the Detection of Ovarian Cancer
PURPOSE: This study is aimed at evaluating serum autoantibodies against four tumor-associated antigens, including LRDD, STC1, FOXA1, and EDNRB, as biomarkers in the immunodiagnosis of ovarian cancer (OC). METHODS: The autoantibodies against LRDD, STC1, FOXA1, and EDNRB were measured using an enzyme-...
Autores principales: | Duan, Yaru, Cui, Chi, Qiu, Cuipeng, Sun, Guiying, Wang, Xiao, Wang, Peng, Ye, Hua, Dai, Liping, Shi, Jianxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904091/ https://www.ncbi.nlm.nih.gov/pubmed/35273656 http://dx.doi.org/10.1155/2022/6657820 |
Ejemplares similares
-
Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021) -
Identification of Novel Autoantibodies Based on the Human Proteomic Chips and Evaluation of Their Performance in the Detection of Gastric Cancer
por: Cui, Chi, et al.
Publicado: (2021) -
Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021) -
Using protein microarray to identify and evaluate autoantibodies to tumor‐associated antigens in ovarian cancer
por: Ma, Yan, et al.
Publicado: (2020) -
Human Proteome Microarray identifies autoantibodies to tumor‐associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma
por: Yang, Qian, et al.
Publicado: (2023)